KNOWLEDGE AND PRESCRIBING PRACTICE OF AMUBULATORY CARE PHYSICIANS ABOUT DISTINCT ANTIBIOTICSTOWARDS TRIVIALRESPIRATORY TRACT INFECTED PATIENTS: STRATEGIES FOR OPTIMAL OUTCOMES AND MINIMIZED RESISTANCE

  • Shaik Kareemulla Department of Pharmacy Practice, P. Rami Reddy College of Pharmacy (PRRMCP), Kadapa
  • S. K. SaiPravalika P. Rami Reddy College of Pharmacy (PRRMCP), Kadapa.
  • Govindu Venkateswarlu Doctor of Pharmacy (Pharm D) 5th Year, P. Rami Reddy College of Pharmacy (PRRMCP), Kadapa
  • P. Nishad Khan Doctor of Pharmacy (Pharm D) 5th Year, P. Rami Reddy College of Pharmacy (PRRMCP), Kadapa
  • K. Sreeharinadh Doctor of Pharmacy (Pharm D) 5th Year, P. Rami Reddy College of Pharmacy (PRRMCP), Kadapa

Abstract

According to World Health Organization (WHO), respiratory tract infections kill 2.6 million children every year worldwide so, it is recognized as the leading cause of morbidity and mortality. Respiratory tract diseases are quite prevalent & more dangerous to the people with weak immune system function. The study was carried out for a period of 90 to 100 days in Rajiv Gandhi Institute of Medical Sciences (RIMS), Kadapa. Antibiotics are prescribed based on symptoms and laboratory investigations. It is a single centered, prospective observational study. Subjects of both genders who indicated with any one antibiotic or its combination are taken in our study and patients who had co morbid pathological conditions also included. Pediatrics, pregnant women and surgical cases were excluded from the study.60 patients (Ambulatory patients) were collected. 36 were male and 24 were female. 20 patients were found to be Literates and 40 patients were Illiterates. 38 patients belong to Lower class, 17 patients belong to Middle class and 5 patients belong to Upper class. 9 patients belong to 15-30 years of age group, 21 patients belong to 31-45 years of age group, 16 patients belong to 46-60 years of age. Ceftriaxone is prescribed in 24 patients, Azithromycin is prescribed in 17 patients, Levofloxacin is prescribed in 7 patients, Ceftriaxone + Augmentin is prescribed in 12 patients.Drug utilization studies used to analyze the different aspects of the use of drugs and to implement ways of improving therapeutic quality. In the present study, pneumonia diagnosed patients (12 patients) received antibiotic combination regimen, while other common respiratory disease patients (48 patients) received single antibiotic during treatment. All the prescribed antibiotics belong to broad spectrums that are effective against most of causative organisms such as Streptococcus, Staphylococcus, Mycoplasma, Klebsiella, Hemophilus etc. In our study, it was also found that, physicians prescribed correct drug in correct dose at correct time through right route of administration for right duration of treatment, it clearly implies that most of the prescriptions found to be Rational.

Keywords: Prescribing Behavior, Trivial Respiratory Tract Infections (RTI), Broad Spectrum Antibiotics,Ambulatory Care Physicians, Cost Effective Prescription

Downloads

Download data is not yet available.

Author Biographies

Shaik Kareemulla, Department of Pharmacy Practice, P. Rami Reddy College of Pharmacy (PRRMCP), Kadapa

Assistant Professor & Institutional Guide, Department of Pharmacy Practice, P. Rami Reddy College of Pharmacy (PRRMCP), Kadapa.

S. K. SaiPravalika, P. Rami Reddy College of Pharmacy (PRRMCP), Kadapa.

Doctor of Pharmacy (Pharm D) 5th Year, P. Rami Reddy College of Pharmacy (PRRMCP), Kadapa.

Govindu Venkateswarlu, Doctor of Pharmacy (Pharm D) 5th Year, P. Rami Reddy College of Pharmacy (PRRMCP), Kadapa

Doctor of Pharmacy (Pharm D) 5th Year, P. Rami Reddy College of Pharmacy (PRRMCP), Kadapa

P. Nishad Khan, Doctor of Pharmacy (Pharm D) 5th Year, P. Rami Reddy College of Pharmacy (PRRMCP), Kadapa

Doctor of Pharmacy (Pharm D) 5th Year, P. Rami Reddy College of Pharmacy (PRRMCP), Kadapa

K. Sreeharinadh, Doctor of Pharmacy (Pharm D) 5th Year, P. Rami Reddy College of Pharmacy (PRRMCP), Kadapa

2Doctor of Pharmacy (Pharm D) 5th Year, P. Rami Reddy College of Pharmacy (PRRMCP), Kadapa

References

1. Baqui, A. H., Rahman, M., Zaman, K., El Arifeen, S.,Chowdhury, H. R., Begum, N., Bhattacharya, A population–based study of hospital admission incidence rate and bacterial etiology of acute lower respiratory infections in children aged less than five years in Bangladesh. Journal of Health, Population and Nutrition, 2007, 2 (5): 179-88.
2. Gauchan P, Lekhak B, Sherchand JB., The Prevalence of lower respiratory tract infection in adults visiting Tribhuvan University Teaching Hospital. Journal of Institute of Medicine, 2006, 28(2): 10-14.
3. Zwart, S, Ruijs G J, Sachs A P Schellekens J F and De Melke R A: Potentially virulent strains and high colony counts of group A streptococci in pharyngitis patients, Journal of Antimicrobial Chemotherapy, 2001, 4(9): 689-91.
4. Kumari, H.B.V., Nagarathna. S, and Chandramuki, A.: Antimicrobial resistance pattern among aerobic gram negative bacilli of lower respiratory tract specimens of intensive care unit patients, Indian. J. Chest. Dis. Allied. Sciences, 2007, 4(3): 19-22.
5. Hirshberg B, Sklair-Levi M, Nir-Paz R, Ben-SiraL, Krivoruk V, Kramer MR, "Factors predicting mortality of patients with lung abscess". American Chest Journal, 1999, 15(3): 746-50.
6. American Thoracic Society (ATS) and Infectious Diseases Society of America (IDSA), adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Medicine, 2005, 17(1):388-416.
7. Melsen WG, Rovers MM, Groenwold RHet al, Attributable mortality of pharyngitis: A meta-analysis of individual patient data from randomised prevention studies. Lancet
Infect Disease, 2013, 1(3):665-71.
8. Sopena N, Sabria M; Neunos Study Group. Multicenter study of pleural effusion in non-ICU patients, journal of Chest, medicine, 2005, 12(7):213-19.
9. Chalmers JD, Rother C, Salih W, Ewig S,chronic bronchitisdoes not accurately identify potentially resistant pathogens: A systematic review and meta-analysis, Clinical Infectious Disease, 2014, 5(8):330-9.
10. A Review of Ceftriaxone for the Treatment of Respiratory tract Infections, Clinical Medicine and Therapeutics, 2009, 6(12): 120-4.
11. A Review of Augmentin for the Treatment of Respiratory tract Infections, Clinical Medicine and Therapeutics, 2009, 6(12): 205-14.
12. A Review of Levofloxacin for the Treatment of Respiratory tract Infections, Clinical Medicine and Therapeutics, 2009, 6(12): 38-46.
13. A Review of Azithromycin for the Treatment of Respiratory tract Infections, Clinical Medicine and Therapeutics, 2009, 6(12): 62-7.
14. Guyatt GH, Oxman AD, Vist GEet al, GRADE: An emerging consensus on rating quality of evidence and strength of recommendations, British Medical Journal, 2008, 33(6):924-6.
15. EsperattiM , Ferrer M, Giunta Vet al, Validation of predictors of adverse outcomes in respiratory tract infections in ICU, Critical Care Medicine, 2013 4(1):2151-61
16. Dudeck MA, Horan TC, Peterson KDet al, National Healthcare Safety Network (NHSN) report, device-associated module, American Journal of Infectious Control, 2011, 3(9):349-67.
Statistics
562 Views | 759 Downloads
How to Cite
Kareemulla, S., SaiPravalika, S., Venkateswarlu, G., Khan, P., & Sreeharinadh, K. (2018). KNOWLEDGE AND PRESCRIBING PRACTICE OF AMUBULATORY CARE PHYSICIANS ABOUT DISTINCT ANTIBIOTICSTOWARDS TRIVIALRESPIRATORY TRACT INFECTED PATIENTS: STRATEGIES FOR OPTIMAL OUTCOMES AND MINIMIZED RESISTANCE. Asian Journal of Pharmaceutical Research and Development, 6(6), 50-55. https://doi.org/https://doi.org/10.22270/ajprd.v6i6.449